In this Aug. 14, 2020, file photo, medical personnel administer COVID-19 testing at a drive-thru site in San Antonio. The number of Americans newly diagnosed with the coronavirus is falling — a development experts credit at least partly to increased wearing of masks — even as the outbreak continues to claim nearly 1,000 lives in the U.S. each day. (AP Photo/Eric Gay, File)
By Carla K. Johnson and Adam Geller
The number of Americans newly diagnosed with the coronavirus is falling — a development experts credit at least partly to increased wearing of masks — even as the outbreak continues to claim nearly 1,000 lives in the U.S. each day.
About 43,000 new cases are being reported daily across the country, down 21 percent from early August, according to data compiled by Johns Hopkins University. While the U.S., India, and Brazil still have the highest numbers of new cases in the world, the downward trend is encouraging.
"It's profoundly hopeful news," said Dr. Monica Gandhi, an infectious-diseases expert at the University of California, San Francisco, who credits the American public's growing understanding of how the virus spreads, more mask-wearing and, possibly, an increasing level of immunity.
"Hopefully all those factors are coming into play to get this virus under control in this country that's really been battered by the pandemic," she said.
The virus is blamed for more than 5.7 million confirmed infections and about 178,000 deaths in the U.S. Worldwide, the death toll is put at more than 810,000, with about 23.7 million cases.
Jeffrey Shaman, a public health expert at Columbia University, said he is skeptical enough people are immune to significantly slow the spread. But he agreed that changes in Americans' behavior could well be making a difference, recalling the impact that people's actions had in containing Ebola in West Africa several years ago.
"Ebola stopped for reasons we didn't anticipate at the time. It was so horrifying that people stopped touching each other," Shaman said. Something similar may be happening with the coronavirus, he said.
"I know I don't have nearly the number of contacts that I used to," Shaman said. "But if we relax that, if we get complacent, will we just see another outbreak?"
The decline in newly reported cases in the U.S. comes even as deaths from the virus remain alarmingly high. Over the past two weeks, officials have reported an average of 965 deaths a day from COVID-19, down from 1,051 a day in early August.
Deaths from the coronavirus are a lagging indicator — they trail new infections because of the time it takes for people to get sick and succumb to the disease.
The percentage of tests coming back positive for the disease has also declined over the past two weeks, from 7.3 percent to 6.1 percent. But that comes as the total number of tests administered has fallen from its August peak of more than 820,000 a day, leveling off in recent weeks at about 690,000 a day.
The situation has improved dramatically in several states that struggled with high caseloads earlier this summer.
In Arizona, for example, officials reported 859 new cases Tuesday, down from a peak of 5,500 in late June. More than 2,000 people arrived at the state's hospitals showing symptoms of the virus on a single day in early July. This week, that number has been less than 1,000.
In Florida, where more than 10,000 people have died, the state reported 2,600 new virus cases Tuesday. Earlier in the summer, it was regularly reporting more than 10,000 new cases.
Malinda Coler, 37, of San Francisco, said she has been diligent about mask wearing and other preventive measures, less to protect herself than a best friend who has a compromised immune system, with severe arthritis psoriasis.
"So I wear a damned mask and get infuriated when others don't," she said.
It's not clear what will happen to case numbers as more school districts bring students back to classrooms and colleges reopen their campuses. In recent weeks, schools including the University of North Carolina, Michigan State, and Notre Dame have moved instruction online after outbreaks on their campuses.
Officials at the University of Tennessee at Knoxville said Monday that four students are facing disciplinary proceedings after three hosted off-campus parties with no mask or other distancing and another left isolation to meet with others despite testing positive for the virus.
"If the facts reported to the university are accurate, these students will face at least suspension from the university, and potentially greater penalties," Chancellor Donde Plowman wrote.
___
Associated Press writers Mae Anderson, Nicky Forster, and John Zenor contributed to this story.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
